CTLA-4 Control over Foxp3 + Regulatory T Cell Function
Kajsa Wing, Yasushi Onishi, Paz Prieto Martín et al. · Science · 2008
Naturally occurring Foxp3+CD4+ regulatory T cells (Tregs) are essential for maintaining immunological self-tolerance and immune homeostasis. Here, we show that a specific deficiency of cytotoxic T lymphocyte antigen 4 (CTLA-4) in Tregs results in spontaneous development of systemic lymphoproliferation, fatal T cell-mediated autoimmune disease, and hyperproduction of immunoglobulin E in mice, and it also produces potent tumor immunity. Treg-specific CTLA-4 deficiency impairs in vivo and in vitro suppressive function of Tregs-in particular, Treg-mediated down-regulation of CD80 and CD86 expression on dendritic cells. Thus, natural Tregs may critically require CTLA-4 to suppress immune responses by affecting the potency of antigen-presenting cells to activate other T cells.
Cited by 2,949 works. doi:10.1126/science.1160062
Authors
- Kajsa Wing
- Yasushi Onishi
- Paz Prieto Martín
- Tomoyuki Yamaguchi
- Makoto Miyara
- Zoltan T Fehervari
- Takashi Nomura
- Shimon Sakaguchi
References
- Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
- Control of Regulatory T Cell Development by the Transcription Factor Foxp3
- Enhancement of Antitumor Immunity by CTLA-4 Blockade
- Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4
- Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4
- Cytotoxic T Lymphocyte–Associated Antigen 4 Plays an Essential Role in the Function of Cd25+Cd4+ Regulatory Cells That Control Intestinal Inflammation
- Immunologic Self-Tolerance Maintained by Cd25+Cd4+Regulatory T Cells Constitutively Expressing Cytotoxic T Lymphocyte–Associated Antigen 4
- B7/CD28 Costimulation Is Essential for the Homeostasis of the CD4+CD25+ Immunoregulatory T Cells that Control Autoimmune Diabetes
- Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma
- Regulatory T Cells and Immune Tolerance